Avandia has had its share of controversy, but is still useful in selected populations. This goes to show how easily a central, psuedo single-payer entity can simply eliminate a major class of medication that is useful to many.
I’d bet if Avandia was a generic, we wouldn’t be having this discussion.
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
